Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Cohn

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Oncogene|January 30, 2007
SPARC enhances tumor stroma formation and prevents fibroblast activationA Chlenski, L J Guerrero, Q Yang, et al.
Pediatric Pathology|November 1, 1993
Evidence for molecular heterogeneity in human ganglioneuroblastomaM L Schmidt, H R Salwen, D Chagnovich, et al.
Neuroscience Letters|October 6, 2000
Synergy between 5' and 3' flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cellsM Gardaneh, J Gilbert, M Haber, et al.
Medical and Pediatric Oncology|July 24, 2001
Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumoursM D Norris, J Gilbert, S A Smith, et al.
Cancer Research|December 1, 1991
Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell lineJ Foley, S L Cohn, H R Salwen, et al.
Journal of the National Cancer Institute|February 5, 1992
RNA expression of the WT1 gene in Wilms' tumors in relation to histologyH Miwa, G E Tomlinson, C F Timmons, et al.
Medical and Pediatric Oncology|December 7, 2000
Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivoD Huang, J L Rutkowski, G M Brodeur, et al.
Cancer Research|November 21, 2000
Schwann cell-conditioned medium inhibits angiogenesisD Huang, J L Rutkowski, G M Brodeur, et al.
Cancer|March 10, 2001
Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literatureP H Shaw, S L Cohn, E R Morgan, et al.
British Journal of Cancer|April 29, 2010
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceK K Matthay, B Shulkin, R Ladenstein, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Oncogene|January 30, 2007
SPARC enhances tumor stroma formation and prevents fibroblast activationA Chlenski, L J Guerrero, Q Yang, et al.
Pediatric Pathology|November 1, 1993
Evidence for molecular heterogeneity in human ganglioneuroblastomaM L Schmidt, H R Salwen, D Chagnovich, et al.
Neuroscience Letters|October 6, 2000
Synergy between 5' and 3' flanking regions of the human tyrosine hydroxylase gene ensures specific, high-level expression in neuroblastoma cellsM Gardaneh, J Gilbert, M Haber, et al.
Medical and Pediatric Oncology|July 24, 2001
Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumoursM D Norris, J Gilbert, S A Smith, et al.
Cancer Research|December 1, 1991
Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell lineJ Foley, S L Cohn, H R Salwen, et al.
Journal of the National Cancer Institute|February 5, 1992
RNA expression of the WT1 gene in Wilms' tumors in relation to histologyH Miwa, G E Tomlinson, C F Timmons, et al.
Medical and Pediatric Oncology|December 7, 2000
Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivoD Huang, J L Rutkowski, G M Brodeur, et al.
Cancer Research|November 21, 2000
Schwann cell-conditioned medium inhibits angiogenesisD Huang, J L Rutkowski, G M Brodeur, et al.
Cancer|March 10, 2001
Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literatureP H Shaw, S L Cohn, E R Morgan, et al.
British Journal of Cancer|April 29, 2010
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceK K Matthay, B Shulkin, R Ladenstein, et al.
Pageof 10